NCT06566222View on ClinicalTrials.gov

Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors

Not yet recruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

August 25, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

Radiotherapy

Interventions

PROCEDURE

chemoradiotherapy after surgery

chemoradiotherapy after surgery vs preoperative chemoradiotherapy

OTHER

High-risk Factors

High-risk Factors vs low-risk Factors

All Listed Sponsors

lead

Changhai Hospital

OTHER

NCT06566222 - Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors | Biotech Hunter | Biotech Hunter